King Ho Leong
What is your current research focused on?
My PhD research is focussed on establishing patient-derived models of metastatic appendiceal cancer. To date, knowledge and resources for appendiceal cancers are very limited due to the rarity of this disease. My PhD research not only aims to generate valuable resources for the wider research community but also provide an essential platform to further our teams drug development work.
What is your study background and when did you decide you wanted to be a research scientist?
I graduated with a Bachelor of Biomedical Science and a Masters of Biotechnology from the University of Adelaide before working as a research assistant for four years in both industry and academic research laboratories. My experience working with many great scientists inspired me to become a research scientist and embark on a PhD at the University of New South Wales and Garvan Institute.
What attracted you to cancer research?
Whilst research has made significant advancements in cancer treatments, certain types of cancer still have limited treatment option and remain associated with lower survival rates. These challenges have are a significant motivation for me. In addition, a fascination with cancer biology has also drawn me to study the complex molecular mechanisms of cancer development and progression.
Why do you think research on metastases is important?
Metastases are the primary cause of cancer deaths, causing many fatal complications and making cancer treatment more difficult to control. Furthermore, metastatic cancer cells often acquire resistance to chemotherapy due to a complex interplay of many factors, such as tumour microenvironment and cell plasticity. Therefore, research on metastases is crucial for overcoming these major challenges in treatment for cancer metastases.
What do you find exciting about your research work?
Through the development of new resources of patient-derived models of appendiceal cancer and a key testing platform for novel drug development, my research work stands to make a valuable contribution not only to the Australian research and technology sector, but also to appendiceal cancer patients and their families. Current standard of care treatments are unable to prevent recurrence in appendiceal cancer patients, even after extensive surgery and chemotherapy treatment. I find my research work in appendiceal cancer very exciting because their opens up the possibility of developing an effective therapeutic strategy to improve the quality of life and clinical outcomes for patients with this rare disease.
What do you hope to achieve in your research career?
Within the next two years, I hope to complete my PhD and start working as an early career researcher, building my track record and developing my research projects. Based on my career experience, I will then seek opportunity for becoming a research project leader in either academic or industrial settings.
Garvan Institute of Medical Research
Email: k.leong@garvan.org.au
LinkedIn: www.linkedin.com/in/kingholeong

